Testimonials
Foundayo (orforglipron) is a newly approved once-daily oral GLP-1 pill for weight management, showing significant results in trials with an average weight loss of approximately 25–27 pounds (11-12% of body weight) at higher doses. Users and experts report high convenience due to having no strict food or water restrictions, with reported side effects including nausea, constipation, and headaches.
In trials, over 54% of participants lost at least 10% of their body weight, and some individuals reported seeing benefits within the first four weeks.
Roger Saris
Weight Loss Efficacy
Unlike other GLP-1 tablets, Foundayo (orforglipron) does not require an empty stomach, offering flexibility to take it with or without food.
Ann Levin
Convenience
While effective, users have reported common gastrointestinal issues, including constipation, diarrhea, and nausea.
Randy Saris
Side Effects
Participants also saw improvements in waist circumference, blood pressure, and triglyceride levels.
Zaire Aminoff
Cardiovascular Health
It is suitable for individuals with obesity or overweight, as listed on Drugs.com.
Hanna Septimus
Eligibility
27.3 pounds (12.4%) at the highest dose over 72 weeks
Luies Michel
Average Loss
Call us
(012) 345 - 6789
Feel free to contact us.
mail@lillyrx.com
Reach to us via our location
View Map